Matthew A Cottam Selected Research

Matthew A Cottam Research Topics

5	Obesity 10/2023 - 11/2018
3	Inflammation (Inflammations) 01/2024 - 01/2021
3	Weight Cycling 11/2023 - 01/2022
3	Weight Loss (Weight Reduction) 11/2022 - 01/2022
2	Metabolic Diseases (Metabolic Disease) 01/2018 - 01/2018
1	Non-alcoholic Fatty Liver Disease 01/2024
1	Fibrosis (Cirrhosis) 01/2024
1	Cardiomegaly (Heart Hypertrophy) 10/2023
1	Heart Failure 10/2023
1	Hypertension (High Blood Pressure) 10/2023
1	Atherosclerosis 10/2023
1	Hyperinsulinism (Hyperinsulinemia) 11/2022
1	Hyperglycemia 11/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Insulin Resistance 01/2021
1	Shock 01/2021
1	Glucose Intolerance 01/2021
1	Iron Overload 01/2021

4	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 01/2021
2	LipidsIBA 11/2023 - 01/2022
2	Insulin (Novolin)FDA Link 11/2022 - 01/2021
1	FructoseIBA 01/2024
1	RNA (Ribonucleic Acid)IBA 11/2023
1	Desoxycorticosterone (Deoxycorticosterone)IBA 10/2023
1	Acetates (Acetic Acid Esters)FDA Link 10/2023
1	SaltsIBA 10/2023
1	Desoxycorticosterone Acetate (DOCA)FDA Link 10/2023
1	CytokinesIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	EpitopesIBA 01/2022
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2022
1	Urethane (Ethyl Carbamate)IBA 01/2022
1	NovoSorbIBA 01/2022
1	PolyestersIBA 01/2022
1	IronIBA 01/2021
1	PolymersIBA 01/2021
1	metal transporting protein 1 (ferroportin)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	isolevuglandinIBA 11/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2018
1	AntigensIBA 11/2018